[
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges",
    "summary": "A social media giant faltered on Thursday, Oct. 30, 2025, as a tax event weighed on its results, while a biotech name benefitted from reports of talks with a major pharma player.",
    "url": "https://finnhub.io/api/news?id=81ef75b062fd22af3d899e0f8e18cae1c128c7416ac2eb9901c7192abc7c34fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761856785,
      "headline": "S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges",
      "id": 137275505,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "A social media giant faltered on Thursday, Oct. 30, 2025, as a tax event weighed on its results, while a biotech name benefitted from reports of talks with a major pharma player.",
      "url": "https://finnhub.io/api/news?id=81ef75b062fd22af3d899e0f8e18cae1c128c7416ac2eb9901c7192abc7c34fc"
    }
  },
  {
    "ts": null,
    "headline": "Moderna stock soars after report of potential buyout talks",
    "summary": "Investing.com -- Moderna (NASDAQ:MRNA) stock surged as much as 12% Thursday following a STAT News report that the COVID-19 vaccine maker has been in discussions with at least one large pharmaceutical company about \"a deal of significant scope,\" which could include a potential acquisition.",
    "url": "https://finnhub.io/api/news?id=1867a86bc3ab33bcba6cfbce52decf14f1c3807ec8ec25e6f28d1f7803c58aa5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761844956,
      "headline": "Moderna stock soars after report of potential buyout talks",
      "id": 137268786,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Investing.com -- Moderna (NASDAQ:MRNA) stock surged as much as 12% Thursday following a STAT News report that the COVID-19 vaccine maker has been in discussions with at least one large pharmaceutical company about \"a deal of significant scope,\" which could include a potential acquisition.",
      "url": "https://finnhub.io/api/news?id=1867a86bc3ab33bcba6cfbce52decf14f1c3807ec8ec25e6f28d1f7803c58aa5"
    }
  },
  {
    "ts": null,
    "headline": "Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline",
    "summary": "Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=f3966375d41ef77d861133e8556a5a55666bf4d7d302d00a1a127d958371aac6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761832836,
      "headline": "Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline",
      "id": 137269895,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=f3966375d41ef77d861133e8556a5a55666bf4d7d302d00a1a127d958371aac6"
    }
  },
  {
    "ts": null,
    "headline": "1 S&P 500 Stock to Research Further and 2 We Find Risky",
    "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
    "url": "https://finnhub.io/api/news?id=b7ab894a54c2d35d453d08a864019279e9dc4c83718e8efe634491db58387eda",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761798856,
      "headline": "1 S&P 500 Stock to Research Further and 2 We Find Risky",
      "id": 137266682,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
      "url": "https://finnhub.io/api/news?id=b7ab894a54c2d35d453d08a864019279e9dc4c83718e8efe634491db58387eda"
    }
  }
]